Position in TGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$127,146,487
+$51,149,493 QoQ
Shares Held
2,314,279
+1.2% QoQ
Ownership
1.51%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 426 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Derivatives in TGTX
reported options exposure · as of Mar 31, 2026CallValue
$7,972,800
CallShares
240,000
PutValue
$18,271,000
PutShares
550,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. TGTX ranks #28 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in TGTX
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $127,146,487 | 2,314,279 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $18,271,000 | 550,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $7,972,800 | 240,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $75,996,994 | 2,287,688 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $61,144,244 | 2,051,132 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $54,887,348 | 1,519,373 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $56,501,022 | 1,569,909 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $75,682,571 | 1,919,416 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $47,388,144 | 1,574,357 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $59,794,825 | 2,556,427 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $37,086,954 | 2,084,708 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $19,566,569 | 1,286,428 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $28,179,214 | 1,649,837 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $14,136,341 | 1,690,950 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $35,306,830 | 1,421,370 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $17,589,309 | 1,169,502 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $14,380,085 | 1,215,561 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $9,128,171 | 1,541,921 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $4,057,385 | 954,679 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $12,671,142 | 1,332,402 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $21,186,254 | 1,115,066 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $36,803,519 | 1,105,875 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $27,462,582 | 707,981 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $64,076,116 | 1,329,380 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $63,798,731 | 1,226,427 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $34,173,188 | 1,277,025 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $21,922,771 | 1,125,399 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $492,000 | 50,000 | Call | Defined | 2020-05-15 | |
| 2020-03-31 | $10,724,369 | 1,089,875 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||